Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 0 0.000% | -2,295,100![]() (Position Closed) | Filing History |
2023-02-14 08:09 am Sale | 2022-12-31 | 13G | CVRx, Inc. CVRX | Soleus Capital Master Fund, L.P. | 1,014,640 4.900% | -29,400![]() (-2.82%) | Filing History |
2023-02-14 08:06 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Soleus Capital Master Fund, L.P. | 0 0.000% | -498,279![]() (Position Closed) | Filing History |
2023-02-14 08:00 am Purchase | 2022-12-31 | 13G | Celcuity Inc. CELC | Soleus Capital Master Fund, L.P. | 2,285,554 9.900% | 1,337,165![]() (+140.99%) | Filing History |
2023-01-30 5:01 pm Purchase | 2023-01-27 | 13G | Jasper Therapeutics, Inc. JSPR | Soleus Capital Master Fund, L.P. | 625,000 5.700% | 625,000![]() (New Position) | Filing History |
2023-01-27 5:02 pm Purchase | 2023-01-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 50,000 5.400% | 37,500![]() (+300.00%) | Filing History |
2023-01-26 5:01 pm Sale | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 12,500 1.300% | -36,061![]() (-74.26%) | Filing History |
2022-11-14 5:00 pm Purchase | 2022-11-11 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,418,977 10.010% | 108,457![]() (+4.69%) | Filing History |
2022-10-13 5:01 pm Purchase | 2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 6,626,063 5.100% | 6,626,063![]() (New Position) | Filing History |
2022-09-28 5:01 pm Purchase | 2022-09-27 | 13G | Edap Tms S.a. EDAP | Soleus Capital Master Fund, L.P. | 4,889,745 13.400% | 1,741,136![]() (+55.30%) | Filing History |
2022-09-02 10:21 am Purchase | 2022-08-31 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 713,964 5.100% | 713,964![]() (New Position) | Filing History |
2022-09-02 10:18 am Purchase | 2022-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Soleus Capital Master Fund, L.P. | 498,279 5.000% | 498,279![]() (New Position) | Filing History |
2022-09-01 09:00 am Purchase | 2022-08-29 | 13G | IRadimed Corporation IRMD | Soleus Capital Master Fund, L.P. | 646,411 5.100% | 646,411![]() (New Position) | Filing History |
2022-05-18 06:06 am Purchase | 2022-05-16 | 13G | Celcuity Inc. CELC | Soleus Capital Master Fund, L.P. | 948,389 6.100% | 948,389![]() (New Position) | Filing History |
2022-04-29 5:01 pm Purchase | 2022-04-28 | 13G | CVRx, Inc. CVRX | Soleus Capital Master Fund, L.P. | 1,044,040 5.100% | 1,044,040![]() (New Position) | Filing History |
2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Edap Tms S.a. EDAP | Soleus Capital Master Fund, L.P. | 3,148,609 9.400% | 1,324,043![]() (+72.57%) | Filing History |
2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,310,521 9.600% | 454,175![]() (+24.47%) | Filing History |
2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,295,100 5.800% | 209,603![]() (+10.05%) | Filing History |
2022-01-27 4:30 pm Purchase | 2022-01-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 48,561 5.400% | 48,561![]() (New Position) | Filing History |
2021-12-20 5:01 pm Purchase | 2021-12-14 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,085,497 5.300% | 2,085,497![]() (New Position) | Filing History |